NeuroSense Therapeutics Ownership | Who Owns NeuroSense Therapeutics?

NeuroSense Therapeutics Ownership Summary

NeuroSense Therapeutics is owned by 2.08% institutional investors, 29.68% insiders, and 68.25% retail investors. Meitav investment house is the largest institutional shareholder, holding 0.18% of NRSN shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.07% of its assets in NeuroSense Therapeutics shares.

NRSN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	NeuroSense Therapeutics	2.08%	29.68%	68.25%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Meitav investment house	40.00K	0.18%	$75.60K
Hrt financial lp	21.69K	0.10%	$41.00K
Commonwealth equity services	16.25K	0.09%	$20.00K
Geode capital management	15.87K	0.09%	$19.04K
Marshall wace, llp	11.83K	0.05%	$22.36K
Jones financial companies lllp	10.92K	0.05%	$20.75K
Hurley capital	6.53K	0.03%	$12.34K
Morgan stanley	1.50K	0.01%	$1.68K
Cwm	1.00K	0.01%	$1.00K
Qube research	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Hurley capital	6.53K	0.01%	$12.34K
Meitav investment house	40.00K	0.00%	$75.60K
Hrt financial lp	21.69K	0.00%	$41.00K
Marshall wace, llp	11.83K	-	$22.36K
Commonwealth equity services	16.25K	-	$20.00K
Cwm	1.00K	-	$1.00K
Two sigma securities	-	-	-
Jane street group	-	-	-
Cantor fitzgerald, l. p.	-	-	-
Stratos wealth partners	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Hrt financial lp	21.69K	0.00%	21.69K
Marshall wace, llp	11.83K	-	11.83K
Jones financial companies lllp	10.92K	-	10.92K
Geode capital management	15.87K	-	3.91K
Commonwealth equity services	16.25K	-	3.63K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-1.58M
Cantor fitzgerald, l. p.	-	-	-79.49K
Renaissance	-	-	-71.10K
Jane street group	-	-	-64.64K
Xtx topco	-	-	-33.71K

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	11.83K	-	11.83K	$22.36K
Jones financial companies lllp	10.92K	-	10.92K	$20.75K

Sold Out

Holder	Change
Qube research	-54.00
Warberg asset management	-10.70K
Ubs group	-11.93K
Two sigma securities	-14.71K
Woodline partners lp	-19.58K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	15	36.36%	449,544	130.66%	2	294.96%	10	233.33%	2	-33.33%
Mar 31, 2025	11	-15.38%	194,892	-69.85%	-	6.54%	3	-70.00%	3	200.00%
Dec 31, 2024	13	85.71%	646,513	186.89%	3	229.84%	10	150.00%	1	-
Sep 30, 2024	7	-	225,356	-86.52%	1	1.06%	4	100.00%	-	-100.00%
Jun 30, 2024	7	-12.50%	1,671,167	899.94%	10	918.60%	2	-33.33%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Nasdaq Composite Index	15.87K	0.07%	-

NRSN Ownership FAQ

Who Owns NeuroSense Therapeutics?

NeuroSense Therapeutics shareholders are primarily institutional investors at 2.08%, followed by 29.68% insiders and 68.24% retail investors. The average institutional ownership in NeuroSense Therapeutics's industry, Biotech Stocks , is 306.59%, which NeuroSense Therapeutics falls below.

Who owns the most shares of NeuroSense Therapeutics?

NeuroSense Therapeutics’s largest shareholders are Meitav investment house (40K shares, 0.18%), Hrt financial lp (21.69K shares, 0.10%), and Commonwealth equity services (16.25K shares, 0.09%). Together, they hold 0.37% of NeuroSense Therapeutics’s total shares outstanding.

Does Blackrock own NeuroSense Therapeutics?

BlackRock is not among the top 10 institutional shareholders of NeuroSense Therapeutics.

Who is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested?

Hurley capital is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 6.53K NeuroSense Therapeutics shares, valued at 12.34K$.

Who is the top mutual fund holder of NeuroSense Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of NeuroSense Therapeutics shares, with 0.07% of its total shares outstanding invested in 15.87K NeuroSense Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools